Kruse Bo
Insider CIK 1752940 · YMAB EVP, CFO, Secy & Treas., Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2024-05-31 | 2024-05-31 | 31,371 | — | $0 | 240,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2024-05-31 | 2024-05-31 | 31,371 | $2.00 | $62.7K | 242,248 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-05-31 | 2024-05-31 | 31,371 | $12.07 | $378.6K | 210,877 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise deriv | 2024-05-30 | 2024-05-31 | 28,629 | — | $0 | 271,371 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2024-05-30 | 2024-05-31 | 28,629 | $12.03 | $344.4K | 210,877 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | M Exercise | 2024-05-30 | 2024-05-31 | 28,629 | $2.00 | $57.3K | 239,506 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-01-18 | 2024-01-22 | 108,900 | — | $0 | 108,900 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-01-18 | 2024-01-22 | 18,100 | — | $0 | 210,877 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2023-01-17 | 2023-01-19 | 70,100 | — | $0 | 70,100 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2023-01-17 | 2023-01-19 | 11,700 | — | $0 | 192,777 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2022-04-26 | 2022-04-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-22 | 2022-02-23 | 4,000 | $7.85 | $31.4K | 181,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-02-04 | 2022-02-07 | 4,000 | $7.97 | $31.9K | 185,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-25 | 4,000 | $9.84 | $39.4K | 189,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 4,000 | $17.12 | $68.5K | 193,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-23 | 4,000 | $16.36 | $65.4K | 197,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2021-12-14 | 2021-12-16 | 85,000 | — | $0 | 85,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 4,000 | $16.35 | $65.4K | 201,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-23 | 4,000 | $18.09 | $72.4K | 205,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-11-04 | 2021-11-05 | 4,000 | $27.54 | $110.2K | 209,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-10-22 | 2021-10-26 | 4,000 | $25.94 | $103.8K | 213,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-10-04 | 2021-10-05 | 4,000 | $28.78 | $115.1K | 217,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-09-22 | 2021-09-23 | 4,000 | $30.82 | $123.3K | 221,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 4,000 | $32.03 | $128.1K | 225,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-23 | 2021-08-24 | 4,000 | $28.60 | $114.4K | 229,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-08-04 | 2021-08-05 | 4,000 | $33.72 | $134.9K | 233,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-07-22 | 2021-07-26 | 4,000 | $34.50 | $138.0K | 237,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-07-06 | 2021-07-07 | 4,000 | $34.15 | $136.6K | 241,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-22 | 2021-06-23 | 4,000 | $36.17 | $144.7K | 245,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-06-04 | 2021-06-07 | 4,000 | $33.48 | $133.9K | 249,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2021-05-24 | 2021-05-26 | 4,000 | $35.61 | $142.4K | 253,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-12-15 | 2020-12-16 | 72,350 | — | $0 | 72,350 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-14 | 2020-05-15 | 28,199 | $36.03 | $1.02M | 257,077 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-14 | 2020-05-15 | 37,847 | $36.03 | $1.36M | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-13 | 2020-05-15 | 14,724 | $37.86 | $557.5K | 285,276 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | S Sale | 2020-05-13 | 2020-05-15 | 19,230 | $37.88 | $728.4K | 37,847 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2020-01-07 | 2020-01-09 | 130,000 | — | $0 | 130,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2018-12-11 | 2018-12-13 | 107,500 | — | $0 | 107,500 | SEC↗ |